Global Allergic Rhinitis Drugs Market 2016-2020- Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Allergic Rhinitis Drugs Market in subject line and your contact details. Read 90 Pages Report at http://www.reportsnreports.com/reports/477144-global-allergicrhinitis-drugs-market-2016-2020.html . Allergic rhinitis is caused by the interaction of airborne allergens with specific immunoglobulin E (IgE) type antibodies on the surface of mast cells. This interaction causes mast cells to release and synthesize chemicals, causing inflammation of the surrounding tissues. Typical symptoms include rhinorrhea, nasal itching, sneezing, and nasal congestion. Extranasal symptoms such as allergic conjunctivitis, itchy ears and palate, and asthma may also occur. Allergic rhinitis is treated using medications such as antihistamines, intranasal corticosteroids, or immunotherapies. Alternative forms of treatment are also employed in certain cases. The analysts forecast global allergic rhinitis market to grow at a CAGR of 0.95% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global allergic rhinitis drugs market for the period 2016-2020. To calculate the market size, it considers revenue generated from the sales of prescription and off-label drugs used to treat allergic rhinitis. The market is divided into the following segments based on geography:
Americas APAC Europe
The report, Global Allergic Rhinitis Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=477144 for US $2500. Key vendors
AstraZeneca
Global Allergic Rhinitis Drugs Market 2016-2020